Scientific Reports (Oct 2021)

Influence of dietary intervention on microvascular endothelial function in coronary patients and atherothrombotic risk of recurrence

  • Marta Millan-Orge,
  • Jose D. Torres-Peña,
  • Antonio Arenas-Larriva,
  • Gracia M. Quintana-Navarro,
  • Patricia Peña-Orihuela,
  • Juan F. Alcala-Diaz,
  • Raul M. Luque,
  • Fernando Rodriguez-Cantalejo,
  • Niki Katsiki,
  • Jose Lopez-Miranda,
  • Pablo Perez-Martinez,
  • Javier Delgado-Lista

DOI
https://doi.org/10.1038/s41598-021-99514-3
Journal volume & issue
Vol. 11, no. 1
pp. 1 – 9

Abstract

Read online

Abstract Endothelial dysfunction is a key player in both the onset and development of atherosclerosis. No study has examined whether healthy dietary patterns can improve microvascular endothelial function in patients with coronary heart disease (CHD) in the long-term and whether this relationship can affect patient’s risk of CHD recurrence. In the CORDIOPREV study, a randomized, double-blind, controlled trial, dietary intervention with either the Mediterranean diet or a low-fat diet was implemented in 1,002 CHD patients. A laser-doppler flowmetry was performed at baseline and after 6 years of follow up in 664 patients, evaluating the effects of this dietary intervention on microvascular basal flow and reactive hyperaemia area, as well as on the risk of CHD recurrence, based on the TRS2P risk score. Basal flow (97.78 ± 2.79 vs. 179.31 ± 5.06 arbitrary perfusion units, 83.38% increase, p 0.05 for the diet-effect). When patients were stratified to low, moderate or high-risk of recurrence, basal flow was similarly increased in all three groups. However, reactive hyperaemia area was improved to a greater extent in patients at the low-risk group compared with those at moderate or high-risk. No differences were observed between diets. Healthy dietary patterns can improve microvascular endothelial function and this improvement persists in the long-term. Patients with a low-risk of CHD recurrence show a greater improvement in reactive vasodilation to ischemia than patients in the moderate or high-risk groups.